A detailed history of Clearstead Advisors, LLC transactions in Iradimed Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 168 shares of IRMD stock, worth $9,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168
Previous 119 41.18%
Holding current value
$9,083
Previous $5,000 60.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.23 - $50.29 $2,118 - $2,464
49 Added 41.18%
168 $8,000
Q2 2024

Aug 09, 2024

BUY
$40.36 - $44.7 $282 - $312
7 Added 6.25%
119 $5,000
Q1 2024

May 14, 2024

BUY
$41.17 - $47.29 $2,387 - $2,742
58 Added 107.41%
112 $4,000
Q4 2023

Feb 12, 2024

BUY
$37.31 - $47.47 $2,014 - $2,563
54 New
54 $2,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $679M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.